Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity

By sjmartinez • September 20, 2024

Mechanick JI, Butsch WS, Christensen SM, Hamdy O, Li Z, Prado CM, Heymsfield SB. Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity. Obes Rev. 2024 Sep 19:e13841. doi: 10.1111/obr.13841. Epub ahead of print. PMID: 39295512.

Tags: Clinical Nutrition, GLP‐1 receptor agonist, Hospitalist, muscle loss, Nutrition, Publications, resistance training, Veterans Administration

The Effects of a Grape Seed Procyanidin Extract on Cytochrome P450 3A4 Activity and Inflammatory Mediators in the Lungs of Heavy Active and Former Smokers

Xue B, Qualls C, Lanthiez A, Lu QY, Yang J, Lee RP, Neis P, Mao JT. The Effects of a Grape Seed Procyanidin Extract on[...]

Response to the Letter to the Editor by Athinarayanan

Almandoz JP, Wadden TA, Tewksbury C, Apovian CM, Fitch A, Ard JD, Li Z, Richards J, Butsch WS, Jouravskaya I, Vanderman KS, Neff LM. Response[...]

Impact of daily avocado consumption on gut microbiota in adults with abdominal obesity: an ancillary study of HAT, a randomized controlled trial

Yang J, Lei OK, Bhute S, Kris-Etherton PM, Lichtenstein AH, Matthan NR, Petersen KS, Sabaté J, Reboussin DM, Lovato L, Vitolins MZ, Rajaram S, Jacobs[...]